ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      59,573.08
      2.91%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lexicon Pharmaceuticals Inc (LXRX)

      7. Lexicon Pharmaceuticals Inc (LXRX) News

      LXRX

      Lexicon Pharmaceuticals (LXRX)

      Lexicon Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LXRX
      DateTimeSourceHeadlineSymbolCompany
      03/16/20108:00AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/16/20107:58AMEdgar (US Regulatory)Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/16/20107:45AMPR Newswire (US)Lexicon Announces Pricing of Common Stock in Public OfferingNASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/15/20109:58PMEdgar (US Regulatory)Registration of Additional Securities (up to 20%) (S-3MEF)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/08/20106:55AMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/08/20106:30AMPR Newswire (US)Lexicon Announces Proposed $95 Million Common Stock OfferingNASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/08/20106:08AMEdgar (US Regulatory)Annual Report (10-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/23/20108:30AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/23/20106:30AMPR Newswire (US)Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Fourth Quarter and Full Year Financial ResultsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/22/20105:02PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/22/20104:59PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/19/20104:12PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/17/20106:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/17/20106:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/17/20105:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/17/20105:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/17/20105:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/17/20105:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/17/20105:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/16/20106:00PMPR Newswire (US)Lexicon to Report Fourth Quarter and Year End 2009 Financial Results on February 23, 2010NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/11/20104:48PMEdgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/03/20106:00PMPR Newswire (US)Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor ConferenceNASDAQ:LXRX
      01/26/20106:15PMPR Newswire (US)Lexicon to Host Conference Call and Webcast to Review Top-Line Phase 2 Results From Diabetes TrialNASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/25/20103:54PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/21/20104:00AMMarketwired(OTC: USOG) Acquisition Strategically Close to Bakken FormationNASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/20/20106:30AMPR Newswire (US)Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic PatientsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/08/20105:09PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/23/20098:30AMPR Newswire (US)Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009NASDAQ:LXRX
      11/20/20098:10AMMarketwiredRidgewater Equity Trend and Financial Analysis of Generex Biotechnology Corp., Allscripts-Misys Healthcare Solutions Inc., LexicNASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/12/20095:07PMPR Newswire (US)Lexicon Announces Positive Phase 2 Results of LX1031 in Non-Constipating Irritable Bowel SyndromeNASDAQ:LXRXLexicon Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:LXRX

      Your Recent History

      BIT
      S31843
      Societe Generale Effekten
      BOV
      ABUD34M
      Anheuser-Busch In Bev SA...
      Delayed Upgrade Clock